Capping patient out-of-pocket costs for insulin has been a popular move for legislators, most recently by the US House. On this episode we weigh the Pros, Cons, and viral reactions to this move including lowering vs. shifting costs, ADA guidelines, and political theater. email: <a href= "mailto:econrxpodcast@gmail.com">econrxpodcast@gmail.com</a> Twitter/Instagram: @EconRx LinkedIn: <a href= "http://www.linkedin.com/company/econrx">www.linkedin.com/company/econrx</a> Website: <a href= "https://econrx.libsyn.com/">https://econrx.libsyn.com/</a>

Capping patient out-of-pocket costs for insulin has been a popular move for legislators, most recently by the US House. On this episode we weigh the Pros, Cons, and viral reactions to this move including lowering vs. shifting costs, ADA guidelines, and political theater. email: econrxpodcast@gmail.com Twitter/Instagram: @EconRx LinkedIn: www.linkedin.com/company/econrx Website: https://econrx.libsyn.com/

Capping patient out-of-pocket costs for insulin has been a popular move for legislators, most recently by the US House. On this episode we weigh the Pros, Cons, and viral reactions to this move including lowering vs. shifting costs, ADA guidelines, and political theater. email:&nbsp;<a href="mailto:econrxpodcast@gmail.com" rel="noopener noreferrer">econrxpodcast@gmail.com</a> Twitter/Instagram: @EconRx LinkedIn:&nbsp;<a href="http://www.linkedin.com/company/econrx" rel="noopener noreferrer">www.linkedin.com/company/econrx</a> Website:&nbsp;<a href="https://econrx.libsyn.com/" rel="noopener noreferrer">https://econrx.libsyn.com/</a>

$35 Insulin Cap

In this show we dive into the business of the US healthcare system. Why are some of my medications covered by insurance but not others? What does it mean for a provider to be "in-network?" Above all, WHERE DO OUR HEALTHCARE DOLLARS GO??! We want to understand and answer these questions, and we want you to come with us on this journey.

Share $35 Insulin Cap

Sign up to save your podcasts

$35 Insulin Cap

$35 Insulin Cap